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1.Introduction 
Thyroid hormones play essential roles in mammalian life, especially in neurodevelopment 
(Porterfield & Hendrich, 1993). This fact is clearly shown in patients with neurological 
deficits from endemic cretinism, who reside in iodine-deficient areas (DeLong et at., 1985). 
In addition to neurological impairments, thyroid dysfunctions, such as hyperthyroidism 
and hypothyroidism, lead to a wide variety of clinical manifestations. Hypothyroidism is 
defined as deficient thyroid hormone action. It is caused most often by decreased thyroid 
hormone production, although in rare cases it is caused by reduced tissue responsiveness 
to or consumptive degradation of the hormone (Huang et al., 2000; Refetoff, Weiss, & 
Usala, 1993). There are two types of deficient thyroid hormone production: primary 
(thyroidal) hypothyroidism and central hypothyroidism. The former is commonly caused 
by iodine deficiency (DeLong et al., 1985) or chronic autoimmune thyroiditis, known as 
Hashimoto’s thyroiditis (Dayan & Daniels, 1996). In iodine-sufficient areas, Hashimoto’s 
thyroiditis is a major cause of primary hypothyroidism. The loss of functional follicles 
caused by intrathyroidal lymphocytic infiltration is attributable to impaired thyroid 
hormone production. Central hypothyroidism is due to reduced thyroid stimulation by 
thyroid-stimulating hormone (TSH) resulting from pituitary disease (secondary 
hypothyroidism) or hypothalamic disease (tertiary hypothyroidism) (Lania et al., 2008). 
Pituitary macroadenomas or radiotherapy of brain tumours and pituitary adenomas are 
frequently associated with insufficient TSH production in adults (Rose, 2001). In some 
cases of central hypothyroidism, abnormally glycosylated TSH with a reduced bioactivity 
is secreted (Faglia et al., 1979; Taylor & Weintraub, 1989). Because thyroid hormones 
negatively regulate pituitary TSH synthesis, decreased serum thyroid hormone 
concentrations lead to the stimulation of TSH production. Therefore, in primary 
hypothyroidism, serum TSH levels are increased, even at the stage of subclinical 
hypothyroidism (Fatourechi, 2009). By contrast, an increase in serum TSH is generally not 
observed in central hypothyroidism because of the impaired hypothalamic-pituitary-
thyroid axis. Based on these observations, serum TSH serves as a useful indicator for the 
presence and the type of hypothyroidism. Therefore, measurements of TSH are quite 
useful in clinical practice (Ladenson et al., 2000).  
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2. Regulation of thyroid-stimulating hormone synthesis 
TSH is produced in pituitary thyrotrophs and activates thyroid follicular cells by binding to 
the TSH receptor (Magner, 1990). This hormone promotes thyroid cell proliferation and 
thyroid hormone synthesis by inducing expression of thyroglobulin, thyroid peroxidase, 
sodium iodide symporter and type I iodothyronine deiodinase (D1) (Tang et al., 1995). TSH 
consists of an ǂ and a  subunit (Shupnik et al., 1989). The ǂ subunit is common to both TSH 
and gonadotropins. The  subunit is a prerequisite for the bioactivity of TSH. Both subunits 
are glycosylated posttranslationally, which is controlled by the thyrotropin-releasing 
hormone (TRH) and is essential for exerting sufficient hormonal bioactivity (Menezes-
Ferreira et al., 1986; Taylor & Weintraub, 1989). In fact, abnormally glycosylated TSH with 
reduced bioactivity is found in some patients with central hypothyroidism (Faglia et al., 
1979; Petersen et al., 1978). 
TSH synthesis is largely dependent on serum thyroid hormone levels. Patients with primary 
hyperthyroidism or primary hypothyroidism consistently demonstrate suppressed or 
increased serum TSH levels, respectively (Ladenson et al., 2000). Clinically, serum TSH 
concentrations serve as a sensitive indicator of thyroid dysfunction since patients with 
abnormal thyroid function have altered serum TSH levels, even at a subclinical stage 
(Fatourechi, 2009). Thus, the measurement of serum TSH is routine for a thyroid evaluation 
in daily clinical practice. In addition to TSH production, the metabolic clearance rate of TSH 
is also influenced by serum thyroid hormone levels, i.e., increased in hyperthyroidism and 
decreased in hypothyroidism (Ridgway et al., 1974). 
In contrast to the negative regulation of TSH production by thyroid hormones, the 
production is positively regulated by TRH. Mice devoid of the TRH gene exhibit 
hypothyroidism accompanied by low circulating TSH levels and reduced numbers of TSH-
immunopositive cells in their pituitary glands (Yamada et al., 1997). In TRH and thyroid 
hormone receptor (TR) -subunit double knockout mice, basal serum TSH levels are low, 
and hypothyroidism fails to increase serum TSH concentrations (Nikrodhanond et al., 2006). 
These studies have demonstrated the pivotal role of TRH in the regulation of TSH 
production. 
Recent studies have demonstrated the presence of TSH receptors in the hypothalamus and 
pituitary folliculo-stellate cells (Crisanti et al., 2001; Prummel et al., 2000), suggesting short 
and ultra-short loop feedback regulation of TSH secretion (Prummel et al., 2004). However, 
their significance remains unknown. 
3. Thyrotropin-releasing hormone as a positive regulator of thyroid-
stimulating hormone production 
TRH is synthesised in neurons located in the parvocellular part of the hypothalamic 
paraventricular nucleus (PVN) (Fekete & Lechan, 2007). These neurons project their axons to 
the median eminence where TRH is released into the portal vein, and the hormone 
subsequently reaches the anterior pituitary. The binding of TRH to its receptor activates 
phospholipase C and is followed by calcium mobilisation and protein kinase C (PKC) 
activation (Carr et al., 1991). However, recent studies suggest that cyclic adenosine 
monophosphate (cAMP) response element binding protein (CREB) rather than the calcium 
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and PKC signalling pathways may play a central role in TRH-stimulated TSH synthesis 
(Hashimoto et al., 2000). In addition, the transcription factor Pit-1, which is pivotal in the 
differentiation of thyrotrophs, lactotrophs and somatotrophs (Andersen & Rosenfeld, 1994), 
induces a synergistic increase in TSH subunit gene transcription in the presence of CREB-
binding protein (Hashimoto et al., 2000). 
TRH synthesis is negatively regulated by thyroid hormones. In the brain, up to 80% of the 
triiodothyronine (T3) bound to nuclear TRs is locally generated through the conversion of 
thyroxine (T4) to T3 by the type 2 deiodinase (D2) (Crantz et al., 1982). Therefore, rather 
than T3, the amount of T4 in circulation is pivotal for the maintenance of adequate T3 
levels in the brain. However, D2 is expressed in the tanycytes lining the third ventricle 
and in astrocytes, but not in neurons (Guadano-Ferraz et al., 1997; Tu et al., 1997). The T3 
produced by tanycytes is the primary source of T3 in TRH neurons. In these neurons, the 
cellular uptake of T3 is mediated by monocarboxylate transporter 8 (MCT8) (Heuer & 
Visser, 2009). T3 binds to the TRs, of which there are three isoforms (TRǂ1, 1 and 2) in 
the brain (Cheng, 2005). Notably, TR2 is central in the suppression of TRH production 
since mice devoid of the TR2 gene exhibit increased TRH gene expression in the PVN 
(Abel et al., 2001). There are consensus sequences for thyroid hormone response element 
(TRE) half-sites (AGGTCA) in the TRH gene, which may be involved in the negative 
regulation of TRH gene expression by T3 (Wilber & Xu, 1998). The promotor region of the 
gene also contains a cAMP response element (CRE) that overlaps with a TRE (Wilber & 
Xu, 1998), which suggests that there is cross talk between the thyroid hormone and 
cAMP-dependent signalling pathways. 
4. Triiodothyronine is a negative regulator of thyroid-stimulating hormone 
production 
Transcription of the TSHǂ and  subunit genes is negatively regulated by T3 (Magner, 1990; 
Shupnik et al., 1989). Mice lacking the TR gene have been shown to exhibit inappropriate 
secretion of TSH (Abel et al., 1999; Weiss et al., 1997). By contrast, TSH subunit expression 
was not altered in mice devoid of the TRǂ gene (Wikstrom et al., 1998). Thus, a series of 
studies suggest a pivotal role for the TR isoforms, especially TR2, in T3-mediated TSH 
suppression. There is a TRE half-site-like sequence (GGGTCA) in the  subunit gene, and 
previous studies have suggested that it might act as a negative TRE in thyrotrophs (Carr et 
al., 1989). However, later studies demonstrated that this putative negative TRE was not 
required in TSH suppression (Matsushita et al., 2007). Instead, the transcription factor 
GATA2 interacts with Pit-1 and TR to play an essential role in both the T3-induced 
suppression and the TRH-induced potentiation of TSH expression (Matsushita et al., 2007; 
Nakano et al., 2004). 
Approximately 50 to 60 % of T3 bound to TRs is locally produced by D2-mediated T4 to T3 
conversion in the rat pituitary gland (Silva & Larsen, 1978). Human pituitary tissues also 
contain D2 (Itagaki et al., 1990). D2 inhibition by iopanoic acid results in an increase in rat 
serum TSH levels (Obregon et al., 1980), which indicates that D2-mediated T4 deiodination 
is the primary source of T3 in the pituitary. D2 activity is increased in hypothyroidism and 
is decreased in hyperthyroidism (Bianco et al., 2002). Thus, the intrapituitary T3 levels are 
carefully maintained by the fine-tuning of D2 activity. 
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5. Neuronal control of thyroid-stimulating hormone secretion (Fig. 1) 
TSH secretion is indirectly controlled by neuronal afferents innervating hypothalamic TRH 
neurons. Adrenergic input from the C1-3 brainstem stimulates TRH synthesis in response to 
cold exposure (Arancibia et al., 1996; Arancibia et al., 1989). Catecholamine binding to ǂ1 
adrenergic receptors leads to CREB phosphorylation and subsequent activation of the TRH 
promoter (Thonberg et al., 2002). Adrenergic neurons that are in contact with the TRH 
neurons also contain cocaine- and amphetamine-regulated transcript (CART) and 
neuropeptide Y (NPY) (Wittmann et al., 2002, 2004). Previous studies have demonstrated 
that CART stimulates TRH synthesis, whereas NPY inhibits it (Fekete et al., 2000, 2001). 
 
III, the third ventricle; AGRP, agouti-related protein; ARC, hypothalamic arcuate nucleus; C1-3, C1-3 
adrenergic area of the brainstem; CART, cocaine- and amphetamine-regulated transcript; D2, type 2 
iodothyronine deiodinase; DMN, hypothalamic dorsomedial nucleus; ǂ-MSH, ǂ-melanocyte 
stimulating hormone; ME, median eminence; NPY; neuropeptide Y; PVN, hypothalamic 
paraventricular nucleus; TRH, thyrotropin-releasing hormone; TSH, thyroid stimulating hormone. 
Fig. 1. Regulatory mechanism of the hypothalamic-pituitary-thyroid axis.  
Peptidergic input from the arcuate nucleus may mediate a fasting-induced decrease in TRH 
production (Lechan & Fekete, 2006). Leptin administration during fasting prevents the 
inhibition of TRH synthesis, suggesting its involvement in this process (Legradi et al., 1997). 
The arcuate nucleus also sends axon terminals containing NPY and agouti-related protein 
(AGRP) or ǂ-melanocyte stimulating hormone (ǂ-MSH) and CART to the TRH neurons and 
thus negatively or positively regulates TRH gene expression (Elias et al., 1998; Hahn et al., 
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1998; Mizuno et al., 1998). Also, ǂ-MSH-containing neurons innervate the hypothalamic 
dorsomedial nucleus (DMN), and the DMN subsequently projects to the TRH neurons in the 
PVN (Mihaly et al., 2001). Thus, there are two pathways to the TRH neurons: the direct 
arcuate-PVN and the indirect arcuate-DMN-PVN. 
6. Drugs affecting thyroid-stimulating hormone secretion 
Glucocorticoids can lower serum TSH concentrations through TRH suppression in the PVN 
(Alkemade et al., 2005; Wilber & Utiger, 1969). TRH neurons possess glucocorticoid 
receptors, and a response element to the hormone has been identified in the TRH gene 
(Cintra et al., 1990). 
Dopamine can reduce TSH production and secretion through its binding to dopamine D2 
receptors in the pituitary gland (Shupnik et al., 1986). Interestingly, it stimulates TRH 
secretion in the rat (Lewis et al., 1987), but this effect cannot override its inhibitory effect on 
the pituitary gland. 
Somatostatin suppresses TSH secretion from the pituitary gland (Lamberts et al., 1989), and 
its analogues are therefore used for the treatment of TSH-producing adenomas (Beck-Peccoz 
et al., 1989). 
In addition to drugs, several cytokines, such as interleukin-1 (IL-1), IL-6 and tumour 
necrosis factor-ǂ (TNFǂ), have been shown to inhibit TSH secretion (Bartalena et al., 1994; 
Pang et al., 1989). These cytokines can stimulate the D2 activity in pituitary cells (Baur et al., 
2000), suggesting increased T4 to T3 conversion as one possible mechanism for the 
suppressed TSH production in cytokine-treated animals. 
7. Quantitative analysis of thyroid-stimulating hormone transcription in 
hypothyroidism (Sugimoto et al., 2007) 
TSH (thyrotropin) is the primary regulatory peptide for the synthesis and secretion of 
thyroid hormones, including T3 and T4. TRH secretion from the hypothalamus stimulates 
the release of TSH from the anterior lobe of the pituitary gland. TSH is then secreted into the 
blood to stimulate the release of T4, which is produced by the thyroid gland, and T3, which 
is produced by both the thyroid gland and by conversion of T4 in peripheral tissues. T3 has 
stronger biological effects than T4. This TRH–TSH–thyroid hormone (T3, T4) secretion 
relationship is called the hypothalamic–pituitary–thyroid axis (HPT axis), which operates on 
both short- and long-feedback mechanisms (O'Shea & Williams, 2002). The plasma levels of 
T3 and T4 are maintained by this mechanism. 
Thyroid hormones are essential for maintaining many physiological functions, including 
metabolism, growth, and development. In hypothyroidism, TSH and TRH levels are 
elevated, owing to the lack of a suppressive action of the T3. Hypothyroidism in rats, 
induced by propylthiouracil (PTU) administration, is associated with high TSH mRNA 
expression, which is measured semiquantitatively by northern blotting or in situ 
hybridisation; however, these results varied widely from 3 to 22 times the level seen in 
control rats (Carr & Chin, 1988; Franklyn et al., 1987; Samuels et al., 1989; Shupnik & 
Ridgway, 1987; Steel et al., 1990; Taylor et al., 1990). 
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The LightCycler® system (Roche Applied Science, Switzerland) was developed for the 
quantitative analysis of gene expression by real-time polymerase chain reaction (PCR). It 
combines a thermocycler and a microvolume fluorimeter (Lyon, 2001) with the fluorescence-
based assay requiring less manipulation than a basic PCR assay (Contini et al., 2005). 
Therefore, the LightCycler® is a highly sensitive quantitative method for the detection of 
RNA expression (Emrich et al., 2002; Schuster et al., 2004; Tan et al., 2004). 
Posttranscriptional control of mRNA steady-state levels can occur at many steps after the 
synthesis of the initial heterogeneous nuclear RNA (hnRNA) transcript. hnRNA is therefore 
the primary transcript produced by RNA polymerase, which includes both the exonic and 
the intronic regions of the DNA. Transcriptional control of the mRNA occurs at the levels of 
hnRNA stability, splicing, polyadenylation, capping, methylation, editing, the nuclear-
cytoplasmic transport of mature mRNA, and mRNA stability. Mature mRNA synthesised in 
the nucleus translocates into the cytoplasm, where it is stabilised, translated into protein, or 
degraded (Kren & Steer, 1996). The half-life of mRNA is comparatively longer than that of 
hnRNA, and changes in mRNA levels in the cell do not necessarily reflect the transcriptional 
level. It takes at least 0.5 h, and sometimes up to 2 h, for mRNA to accumulate to detectable 
levels after the start of transcription for most genes (Kren & Steer, 1996). A more reliable 
measure for evaluating the rate of transcription is hnRNA because of its short half-life of 15–
30 min (Darnell, 1983), which makes it a valuable quantitative indicator of transcriptional 
activation. 
In 2002, Johnson et al. (Johnson et al., 2002) reported a quantitative real-time reverse 
transcription (RT)-PCR analysis of prostaglandin endoperoxide H synthase hnRNA. Since 
then, several studies have successfully detected hnRNA expression using real-time PCR 
systems (Danzi et al., 2005; Ginsberg et al., 2006; Johnson et al., 2003; Kuroda et al., 2005; Li 
et al., 2005). However, only semiquantitative analyses of hnRNA have been reported for 
TSH gene transcription (Franklyn et al., 1987; Samuels et al., 1989; Shupnik & Ridgway, 
1987; Taylor et al., 1990). In this study, we performed a quantitative analysis of TSH gene 
expression by real-time RT-PCR using the LightCycler® system. We present here the first 
quantitative demonstration of increased mRNA and hnRNA expression of TSH under a 
chronic condition of hypothyroidism in rats. This method for the detection of quantitative 
hnRNA is illustrated in Fig. 2.  
7.1 Materials and methods 
7.1.1 Animals and the induction of hypothyroidism 
Adult male Wistar rats (Nippon Clea Inc., Shizuoka, Japan) weighing 280 g were allowed free 
access to food and water and were maintained on a 12 h light/12 h dark cycle (lights on 07:00–
19:00 h). The rats were divided into two groups of four animals each: a hypothyroidism group 
and a control group. The rats were allowed free access to either 0.05% methimazole (MMI) in 
water (hypothyroid group) or water alone (controls). Fourteen days later, all rats were 
decapitated between 08:00 and 10:00 h, and blood was collected from their trunks to avoid 
contamination with the pituitary portal blood, which contains high TSH levels. The sample 
was collected into a tube containing ice-cold ethylenediaminetetraacetic acid (EDTA) and 
centrifuged at 1008×g for 30 min. Serum T3 and T4 levels were measured to assess the degree 
of hypothyroidism induced by MMI administration. 
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All animal experiments were conducted in accordance with the international standards for 
animal welfare from the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals and the Animal Experiments Guidelines of the Institute for Animal 
Experimentation, Tohoku University Graduate School of Medicine. 
 
Real-time PCR was performed using the cDNA as a template, which was reverse transcribed from total 
RNA. The intron-specific primer pair was used to amplify hnRNA for primary transcript quantification. 
Figure modified from Strachan, T & Read, AP. (2004). DNA structure and gene expression, In: Human 
Molecular Genetics 3rd, pp15, Garland Science, ISBN 0-8153-4184-9, New York, USA.  
Fig. 2. Our method for the detection of quantitative hnRNA.  
C㼛㼚㼢㼑㼚㼠㼕㼛㼚a㼘 RT-㻼CR 
㻻㼡r 㼙㼑㼠㼔㼛㼐 
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7.1.2 Assay of serum T3 and T4 by EIA 
Serum samples taken from the trunk blood were analysed for T3 and T4 levels by an 
Enzyme Immunoassay (EIA) kit (IMX Dynapac, Abbott Japan, Tokyo, Japan). The 
sensitivities of the assay were <15 ng/dl for T3 and 1.0 ug/dl for T4.  
7.1.3 RNA isolation and reverse transcription for real-time PCR 
Following decapitation, the rat brains were removed within 1 min. The pituitaries were 
dissected out, snap frozen in liquid nitrogen, homogenised and treated with a combination 
of Trizol and chloroform (Invitrogen, San Diego, CA) to extract total RNA (Guevremont et 
al., 2006). The RNA from the rat pituitary was purified using DNase I to remove genomic 
DNA, and the RNA concentration was determined by absorbance readings at 260 nm on a 
UV spectrophotometre (Bio-Rad, Hercules, CA). A total of 2 µg of RNA was reverse 
transcribed using the Omniscript Reverse Transcription (RT) kit (Qiagen, Hilden, Germany) 
with random hexamer primers. Refined cDNA was synthesised in a total volume of 20 ul, 
treated with RNase H and stored at −20°C until use.  
The integrity of the RNA used for the cDNA preparations was tested by PCR 
amplification (using a thermal cycler) of the glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) housekeeping gene (primer sequences are listed in Table 1). After 
electrophoresis on 2% agarose gels, staining with ethidium bromide and visualisation by a 
UV light, the sizes of the PCR products were verified by comparing them against 
molecular weight markers. 
 
 Forward primer 5’ – 3’ Reverse primer 5’ – 3’ Product size 
TSHǃ mRNA ggcaaactgtttcttcccaa gttggttttgacagcctcgt 210 bp 
TSHǃ hnRNA gaccagtgatccagtcggtt cgggctgtagaaaccaggta 447 bp 
GAPDH mRNA tgaacgggaagctcactgg tccaccaccctgttgctgta 307 bp 
Primers were designed using the computer programme Primer 3 Software 
(http://frodo.wi.mit.edu/cgibin/primer3/primer3_www.cgi). 
All the produced sequences were checked for homology by the NCBI database BLASTn. 
Table 1. Primer sequences for quantitative real-time RT-PCR. 
7.1.4 Primer design and quantitative analysis by real-time PCR 
TSH primers were designed to amplify two specific regions in the TSH RNA. To amplify 
mRNA, the exon-specific primer pair, which was designed to target sequences from exon 3, 
was used (Table 1). The intron-specific primer pair, which was designed to target sequences 
found in intron 1, was used to amplify hnRNA (Table 1). The amplified mRNA and hnRNA 
products were 210 and 447 bp, respectively. All RT-PCR assays were normalised against rat 
GAPDH using commercial PCR primers (Nihon Gene Research Laboratories) that amplify a 
307 bp product (Table 1).  
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Quantification of the TSH mRNA and hnRNA was performed by real-time PCR using 
the LightCycler® system (Roche Diagnostics, Japan) with SYBR green detection of 
amplification products. PCR for all genes was performed in a final volume of 20 ul using 
the LC FastStart DNA Master SYBR Green I (Roche Molecular Biochemicals) with 2 ul of 
each primer at 0.5 M, 3 mM MgCl2 and 2 ul of extracted cDNA, but without dimethyl 
sulfoxide (DMSO). 
Table 2 shows the LightCycler® PCR amplification programmes. A single fluorescence 
reading for each sample was taken at the annealing step. Quantitative results were 
determined from the crossing point (CP), which marked the cycle when the fluorescence of a 
given sample significantly exceeded the baseline signal, and are expressed as a fractional 
cycle number. CP values plotted against known concentrations of TSH mRNA and hnRNA 
were used to obtain a standard curve. The TSH mRNA and hnRNA counts for 
 
Gene 
 Programme for Real-time LightCycler 
Melting curve 
 Denaturation Annealing Elongation 
TSH mRNA 
(cycles 45) 
Temperature 
(°C) 
95 62 72 95 62 96 
Incubation time 
(sec) 
10 10 20 0 15 0 
Temperature 
transition rate 
(°C/sec) 
20 20 20 20 20 0.1 
TSH 
hnRNA 
(cycles 45) 
Temperature 
(°C) 
95 62 72 95 62 96 
Incubation time 
(sec) 
10 10 20 0 15 0 
Temperature 
transition rate 
(°C/sec) 
20 20 20 20 20 0.1 
GAPDH 
mRNA 
(cycles 45) 
Temperature 
(°C) 
95 62 72 95 62 96 
Incubation time 
(sec) 
10 10 20 0 15 0 
Temperature 
transition rate 
(°C/sec) 
20 20 20 20 20 0.1 
Table 2. LightCycler PCR amplification conditions. 
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a given rat sample were calculated by interpolation from this standard curve (Software 
LightCycler® 3.5). The melting point of each amplified product was calculated to check the 
PCR specificity (Fukushima et al., 2003), and transcription of each cDNA was quantified 
(Fig. 3). 
 
The horizontal and vertical axes show the PCR cycle number and the degree of fluorescence, 
respectively. In the hypothyroid rat group, the PCR amplification lines curve upward at lower PCR 
cycle numbers than those of the control group, indicating that the initial hnRNA content was higher in 
the hypothyroid rat group than in the control group.  
Figure Inset: The unknown relative concentration of hnRNA can be calculated from the sample 
concentration (the horizontal axis; log X) and the cycle number (the vertical axis).  
Fig. 3. Original graph from the LightCycler® 3.5 system for the quantification of TSH 
hnRNA.  
7.1.5 Statistical analysis 
All data are expressed as means ± S.D. T3 and T4 measurements and real-time PCR data 
were analysed for statistical significance using an unpaired Student’s t-test. A p-value less 
than 0.01 was considered statistically significant difference. 
Control Hypothyroidism
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7.2 Results 
7.2.1 Serum T3 and T4 levels 
The serum T3 and T4 levels for the hypothyroid rats and control rats are listed in Table 3. 
Oral administration of 0.05% MMI ad libitum was sufficient to induce hypothyroidism in 
rats. MMI administration resulted in a complete suppression of T3 levels.  
 
 T3 T4 
Hypothyroidism n.d.* 1610 ± 1100* 
Control 48.7 ± 2.1 6730 ± 210 
Values are means ± SD. *p < 0.01 compared with the control group. Not detected (n.d.). 
Table 3. Serum T3 and T4 levels (ng/dl).  
7.2.2 Quantitative analysis of TSHβ mRNA and hnRNA by real-time PCR 
TSH gene regulation at the transcriptional and posttranscriptional levels was evaluated by 
real-time RT-PCR to assess mRNA and hnRNA (mRNA precursor) expression. The total 
RNA extracts from pituitaries isolated from weight-matched rats were treated with DNase 
I to remove contaminating genomic DNA prior to RT-PCR. The TSH-specific primers 
were subsequently checked for their ability to amplify during PCR reactions in the 
thermal cycler using total RNA with or without DNase I treatment. Although a PCR 
product was created from the total RNA template in the absence of DNase I (Fig. 4), the 
presence of DNase I inhibited the reaction, and no product was produced (data not 
shown).  
The TSH mRNA and hnRNA levels measured from real-time RT-PCR analysis were 
estimated relative to the values of GAPDH (the internal standard) and expressed as 
percentages of the control (Fig. 5). The expression levels of both TSH mRNA and hnRNA 
in hypothyroidism were approximately fourfold higher than the respective levels in control 
rats. The difference in CP between TSH mRNA and hnRNA was approximately 3–5 (Fig. 
3), indicating that hnRNA expression was 8- to 32-fold lower than mRNA expression in 
chronically hypothyroid rats.  
7.3 Discussion  
The aim of this study was to detect hnRNA expression by quantitative real-time PCR 
analysis, and, in particular, the up-regulation of TSH gene transcription under the 
condition of hypothyroidism. Previous reports have shown a range of levels for the up-
regulation of TSH mRNA (Table 4). Although these results were obtained under different 
experimental conditions, such as the length of PTU administration and the method of 
mRNA detection, our results confirmed a significant increase in TSH mRNA expression in 
hypothyroid rats.  
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Both bands ofthe TSH mRNA and the hnRNA bands in the hypothyroid rats group looked were 
thicker than that those in the control group. The far left lanes show ladder is a DNA markerladder. 
After checking the size of the PCR ampliconslength by this ladder, we can forward proceed to the next 
step for a quantitative real-time PCR. Hypothyroid rats group: lanes 1-4. Control group: lanes 5-7.  
Fig. 4. Detection of the RT-PCR amplicons for TSH mRNA and hnRNA by thermal cycler 
 
TSH mRNA and hnRNA levels in hypothyroid rats were approximately fourfold higher than those of 
the control rats. Control values were normalised to 100%. Data are expressed as means ± S.D. *p < 0.01 
compared with the control group. 
Fig. 5. Quantitative analysis of TSH mRNA and hnRNA levels in control and hypothyroid 
rats using a LightCycler® PCR system.  
1        2        3       4 
Hypothyroidism 
5       6      7 
Control 
TSHß mRNA TSHß hnRNA
1        2        3       4 
Hypothyroidism 
5      6       7 
Control 
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Most previous reports have used PTU to induce hypothyroidism (Franklyn et al., 1987; 
Samuels et al., 1989; Shupnik & Ridgway, 1987; Taylor et al., 1990). However, there is 
ample evidence that MMI should be used first as an antithyroid drug for Graves’ disease 
(Ginsberg et al., 2006). In addition, some studies have shown that MMI is more effective 
than PTU at equivalent doses by reducing thyroid hormone levels more rapidly and 
achieving euthyroidism more quickly (Ginsberg et al., 2006). In this study, free access to a 
0.05% MMI solution in drinking water for 2 weeks induced hypothyroidism in rats (Table 
3). Because of its longer half-life, MMI can also be used as a single daily agent and is 
therefore more likely to be associated with patient compliance (Cooper, 1984, 1986). Most 
importantly, MMI may have a more favourable safety profile than PTU (Ginsberg et al., 
2006).  
 
Reference 
Duration of PTU 
administration 
TSH mRNA Method 
(Taylor et al., 1990) 
2 weeks 4-fold up-regulation in situ 
hybridisation 4 weeks 16-fold up-regulation 
(Steel et al., 1990)  22-fold up-regulation 
in situ 
hybridisation 
(Samuels et al., 
1989) 
6 weeks 3-fold up-regulation 
Northern blot 
analysis 
(Carr & Chin, 1988)  6- to 8-fold up-regulation 
Northern blot 
analysis 
(Shupnik & 
Ridgway, 1987) 
6 weeks 10-fold up-regulation 
Northern blot 
analysis 
(Franklyn et al., 
1987) 
3 weeks 10-fold up-regulation Northern blot 
analysis 10 weeks 20-fold up-regulation 
PTU administration; oral administration of 0.05% propylthiouracil in the drinking water  
Table 4. Previous reports of semi-quantitative analysis of TSHǃ mRNA expression in rat 
hypothyroidism. 
In this study, we accurately measured the increased rate of TSH gene transcription in 
hypothyroid rats by detecting mRNA and hnRNA expression levels over time using the 
LightCycler® system. Our main recommendations for success with this system are as 
follows: (1) the extracted total RNA should be treated with DNase to ensure exclusion of 
genomic DNA and (2) degenerate oligonucleotide random primers should be used instead 
of the degenerate oligonucleotide dT primers that are more commonly used for mRNA 
detection.  
The poly-A tail of a mature mRNA is immediately appended by poly-A polymerase at the 
final step of RNA processing. Oligonucleotide dT primers attach to the poly-A tail of the 
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mRNA for cDNA synthesis until the RT reaction stops. Therefore, only the exonic regions of 
the DNA are reflected by RT-PCR when use of Oligonucleotide dT primers. However, in our 
experiments, we used a random hexamer primer, which attaches to DNA complementarily 
and randomly. When a hexamer primer attaches to any intronic region of the hnRNA, the 
RT reaction accurately makes cDNA, reflecting primary transcription. Using this cDNA 
containing intronic sequences as a template, we successfully amplified primary TSH 
transcripts with a TSH-specific intron primer.  
The only difficulty in our method was dissecting tissues of the same size and location 
from the animals. In this study, we easily removed pituitary glands of the same size 
because the pituitary gland differentiates from a dual embryonic origin, unlike other 
nearby tissues (Kelberman et al., 2009), which allows the pituitary gland to be easily 
separated. However, in the case of continuous tissues, such as the hypothalamus, it may 
be difficult to dissect an area from the same location within the brain. If the dissected area 
dose not contain the target neurons, the internal gene of the area should show a relative 
increase.  
The increased level of TSH mRNA was nearly equal to that of TSH hnRNA in 
hypothyroid rats. Since the transcriptional rate is often masked by the abundance of pre-
existing mature mRNA, quantitative detection of hnRNA is important for the precise 
examination of transcriptional changes during an acute response. Therefore, the use of a 
quantitative real-time PCR method is beneficial for the analysis of genes with low 
expression levels, such as those genes that are undetectable when using an in situ 
hybridisation method.  
In this report, we demonstrated for the first time that optimal conditions for real-time PCR 
enable the detection of TSH hnRNA expression levels in hypothyroid rats. In addition to its 
critical role in homeostasis, thyroid hormone can also regulate gene transcription in relation 
to various aspects of brain function (Refetoff et al., 1993), including synapse formation 
(Nicholson & Altman, 1972). Thus, our results are of particular importance for 
neuroendocrinological studies. 
Finally, we determined the exact ratio for the up-regulation of TSH mRNA and hnRNA 
levels in hypothyroid rats using quantitative real-time PCR. Using this method, we can 
perform similar investigations on the transcription rates of other genes. 
8. Conclusion 
We have summarised TSH regulation (e.g., TSH secretion and synthesis), the HPT axis as a 
positive/negative regulator of TSH, the neuronal control of TSH, and drugs affecting TSH in 
hypothyroidism. We also described a method for the quantitative analysis of TSH hnRNA 
and mRNA expression using real-time PCR in induced hypothyroidism. Both the TSH 
mRNA and hnRNA expression levels in hypothyroidism induced by methimazole 
administration were increased approximately fourfold over the respective levels in control 
rats. Further, the level of TSH hnRNA expression was 8- to 32-fold lower than that of TSH 
mRNA in chronically hypothyroid rats. Using this method, we can perform similar 
investigations of the transcription rates for other genes. 
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